Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
Intracellular effects of the Hepatitis C virus nucleoside polymerase inhibitor RO5855 (Mericitabine Parent) and Ribavirin in combination. [electronic resource] by
- Ma, H
- Le Pogam, S
- Fletcher, S
- Hinojosa-Kirschenbaum, F
- Javanbakht, H
- Yan, J-M
- Jiang, W-R
- Inocencio, N
- Klumpp, K
- Nájera, I
Producer: 20150515
In:
Antimicrobial agents and chemotherapy vol. 58
Availability: No items available.
|
|
|
11.
|
Characterization of hepatitis C virus (HCV) quasispecies dynamics upon short-term dual therapy with the HCV NS5B nucleoside polymerase inhibitor mericitabine and the NS3/4 protease inhibitor danoprevir. [electronic resource] by
- Le Pogam, S
- Yan, J M
- Chhabra, M
- Ilnicka, M
- Kang, H
- Kosaka, A
- Ali, S
- Chin, D J
- Shulman, N S
- Smith, P
- Klumpp, K
- Nájera, I
Producer: 20130423
In:
Antimicrobial agents and chemotherapy vol. 56
Availability: No items available.
|
|
|
12.
|
In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor. [electronic resource] by
- Javanbakht, H
- Ptak, R G
- Chow, E
- Yan, J M
- Russell, J D
- Mankowski, M K
- Hogan, P A
- Hogg, J H
- Vora, H
- Hang, J Q
- Li, Y
- Su, G
- Paul, A
- Cammack, N
- Klumpp, K
- Heilek, G
Producer: 20100621
In:
Antiviral research vol. 86
Availability: No items available.
|